According to the new report “Global Smart Phone Enabled Healthcare Diagnostics Market Assessment & Forecast: 2016 - 2020” by SA-Business Research & Consulting Group, Cardiology and Hematology were largest medical applications for introducing commercial and marketable smart phone enabled diagnostic devices. Continuous glucose monitoring, blood pressure monitoring, ECG and pulse oximetry were the most adopted devices using smart phones as a platform. In 2015 the smart phone enabled cardiology diagnostics market was valued at US$ 1,991.3 million and is forecast to grow to US$ 4,812.3 million by 2020 at a CAGR of 19.2% from 2016 to 2020.
Developing economies in regions such as Africa, Asia-Pacific, Latin America and Eastern Europe lack required number of medical professionals in certain medical specialties such as respiratory diseases. Smart phone enabled diagnostics for sexually transmitted diseases such as HIV and Syphilis can help prevent deaths potentially numbering into millions since most of these diseases are identified too late. The rate of diagnosing diabetes and other chronic illnesses are also very low in remote villages since equipment may be expensive for small clinics to purchase or diagnostic test may be too expensive for people. According to International Diabetes Federation and Routledge Handbook of Global Public Health in Asia, over 50% people may be undiagnosed for diabetes. Innovating affordable, portable smart-phone enabled devices to diagnose and monitor developing regions diseases such as malaria, tuberculosis, HIV and other major “high-mortality” conditions will open a large revenue generating possibility in coming years.
Excellent internet connectivity among developed nations will continue to push market in coming years. Although developing countries such as Brazil, Mexico, India and several others have a high penetration of smart phones, the lack of stable telecommunications infrastructure will prevent adoption to a great degree throughout the forecast period. Asia-Pacific has one of the largest aging populations and also accounts for over half of world’s diabetics. As strong scientific evidence suggests diabetics to be more prone to cataracts, SA-BRC anticipates that the market for smart phone enabled diagnostics such as glucometers and lens attachments for smart phones will increase tremendously in coming years and boost the diagnostic rates. The diagnosis of cardiovascular diseases, diabetes, ophthalmology and sexually transmitted infections is anticipated to churn greatest revenue post the technology’s penetration into the regions.
It is estimated that by 2016 over 2 billion people will have purchased a smart phone and a large percentage of this population use smart phones for functions besides music, calls and clicking photos. Over 550 million are anticipated to use smartphone users worldwide will be using health-related apps. Awareness and increased comfort of technology particularly among aging population has prompted independence in taking care of illnesses at home by patients. The availability of easy to understand smart phone based devices will further propel the adoption. Analysts at SA-BRC anticipate that an additional niche segment is childcare at home wherein parents resort to smart phone enabled diagnostics to routinely monitor fever, ear-nose-throat infections, skin infections among others that affect young children. Smart phones are capable of taking pictures and analysing dermatological disorders or skin disorders and will provide parents with the proper steps to combat the diseases.
The market is highly fragmented in all 3 areas of hardware, software and services. This report covered notable companies such as AliveCor, iHealth, Cerora, Philips Healthcare, Glooko Inc, McKesson Israel ltd, Shanghai Berry Electronic Tech Co., Ltd AkibaH Inc, Gentag, CellScope, EyeNetra, Entra Health, SonoStar Technologies, Mobisante, Nonin, OJ-Bio, Mega Electronics, Holomic LLC, MobileODT, CardioSecur, SHL Telemedicine, Welch Allyn, Hera Med, Samsung, and Calgary Scientific among others.
Our reports have been used by over 10K customers, including:
Colorectal Cancer Screening Market Report Overview Colorectal Cancer Screening market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Colorectal Cancer Screening market types and applications. It is a focused study on Colorectal Cancer Screening...
Mononucleosis Diagnostic Market Report Overview Mononucleosis Diagnostic market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Mononucleosis Diagnostic market types and applications. It is a focused study on Mononucleosis Diagnostic market...
Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics Market Report Overview Non-alcoholic Steatohepatitis (NASH) Therapeutics and Diagnostics market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Non-alcoholic Steatohepatitis...
Rubella Diagnostic Testing Market Report Overview Rubella Diagnostic Testing market size outlook report provides comprehensive coverage of market landscape including strategic growth areas, unique insights, and major trends across Rubella Diagnostic Testing market types and applications. It is a focused study on Rubella Diagnostic Testing...
196 pages •
By Global Industry Analysts
• Apr 2021
- Global Imaging Agents Market to Reach $12.9 Billion by 2027
- Amid the COVID-19 crisis, the global market for Imaging Agents estimated at US$10.4 Billion in the year 2020, is projected to reach a revised size of US$12.9 Billion by 2027, growing at a CAGR of 3.1% over the analysis period 2020-2027. Diagnostic...
236 pages •
By Global Industry Analysts
• Apr 2021
- Global Automated and Rapid Microbiological Tests Market to Reach $7.8 Billion by 2027
- Amid the COVID-19 crisis, the global market for Automated and Rapid Microbiological Tests estimated at US$5.2 Billion in the year 2020, is projected to reach a revised size of US$7.8 Billion by 2027, growing at a CAGR...
370 pages •
By Global Industry Analysts
• Apr 2021
- Global Urinalysis Market to Reach $2.4 Billion by 2027
- Amid the COVID-19 crisis, the global market for Urinalysis estimated at US$1.6 Billion in the year 2020, is projected to reach a revised size of US$2.4 Billion by 2027, growing at aCAGR of 6.4% over the period 2020-2027. Consumables, one of the segments...
The global generic oncology drugs market exhibited strong growth during 2015-2020. Generic oncology drugs assist in shrinking, controlling and destroying the cancer cells present in the human body. Furthermore, a few oncology drugs are widely prescribed by doctors to alleviate symptoms, including pain. They share the...
KEY FINDINGS The global sepsis diagnostics market is projected to grow at a CAGR of 8.06% during the forecast period, 2021-2028. The rising government initiatives, the growing burden of sepsis, the spread of infectious diseases, and complications due to hospital-acquired infections (HAIS), propel market growth. MARKET...
The Asia Pacific pre-lit disposable vaginal speculum market is expected to reach US$ 79.35 million by 2027 from US$ 57.80 million in 2019. The market is estimated to grow at a CAGR of 4.1% from 2020 to 2027. Key factors that are driving the market include high prevalence of cervical cancer and increase in government initiatives for cervical...
Cervical Cancer Screening Coverage
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.